Deregulated expression of genes is found in cancer cells, which may aect malignant properties, but it is unclear whether such modulation occurs allele-speci®cally. This study shows that the gene coding a4 integrin, a cell adhesion molecule, underwent allelic inactivation in a series of heterozygous murine ®brosarcoma cell lines (MST lines) with dierent metastatic potentials. P4 cells expressed the a4 integrin gene from one allele at a level comparable to that of the primary MST1 tumor, whereas the descendent lines of P4 exhibited decreased expression of both alleles. No allelic loss of DNA was observed in these cells. Other four clones derived from P4 and ®ve clones from a dierent tumor also showed such two-step inactivation. Intriguingly, the loss of expression was correlated with the acquisition of spontaneous, but not arti®cial, metastatic ability. This is consistent with the previous result of inverse relation between the expression of a4b1 integrin and the invasive potential of B16 melanoma cells. Analysis of DNA methylation and chromatin state of the a4 integrin gene failed to provide a clue to dierence between the two alleles in the cell lines. These results suggest that the allelic inactivation is a process giving loss of function to one allele, although the mechanism is unclear.
Introduction
Tumor cells often show dierent gene expressions as compared with their normal counterparts which underlie cancer phenotypes (Zhang et al., 1997) . Dierences of some genes are known to give strong in¯uences; i.e., deregulation of the p53 and p16 tumor suppressor genes and c-myc oncogene have been recognized as factors in the cancer development (Han and Kulesz-Martin, 1992; Ueda et al., 1995; Rodriguez-Alfageme et al., 1992) , and loss or down-regulation of some cell adhesion molecules is one of the abnormalities correlated to tumor progression (Qian et al., 1994; Risinger et al., 1994; Ochiai et al., 1994; Yoshiura et al., 1995) . This modulation of expression may be due to epigenetic modi®cations of the gene region such as DNA methylation (Adams and Burdon, 1982; Antequera and Bird, 1993; Laird et al., 1995) and therefore can occur allele-speci®cally. In fact, we previously demonstrated that the three genes for p53, E-cadherin and Glut3 showed allelic inactivation in MST tumor cells that were derived from intersubspeci®c F 1 mice between C57BL/6 and MSM (Ohtsuka et al., 1994) . According to Knudson's two hit theory (Knudson, 1985) , the total loss of function of a given gene is achieved by inactivation of both alleles by a variety of mechanisms. Epigenetic inactivation might be one of the mechanisms. However, study of allelespeci®c expression of genes in tumor cells has received little attention relative to loss of heterozygosity analysis, probably because of lower frequencies of polymorphisms at the RNA level.
Integrins are cell adhesion molecules comprising an a and a b subunit, each with a transmembrane domain and a short cytoplasmic sequence. They mediate cellmatrix and cell-cell interactions (Hynes, 1992; Ruoslahti and Reed, 1994) and play important roles in tumor progression and metastasis (Qian et al., 1994; Paavonen et al., 1994) . Introduction of the a4 integrin gene into metastatic melanoma cells inhibits the metastasis formation at the invasive stage (Qian et al. 1994) . This indicates that the inactivation of a4 integrin gene is a factor required for spontaneous metastasis of the melanoma line. Our preliminary examination of the a4 integrin gene revealed that the gene also lost expression allele-speci®cally in the MST tumor cells. Thus, we have tested relationship between this allelic inactivation and spontaneous tumor metastasis using a series of MST tumor cell lines with dierent metastatic properties. This paper demonstrates allelic inactivation of the a4 integrin gene and shows its possible involvement in acquisition of spontaneous metastatic ability. The results lead to an implication that allelic inactivation may be an important process for loss of function of one allele in tumor cells.
Results

Allele-speci®c gene expression of a4 integrin in MST cells
We searched a polymorphism of the a4 integrin cDNA by SSCP analysis between two mouse strains, C57BL/ 6(B6) and MSM and found it in the 3' noncoding region. Sequence analysis showed one-base substitution from C to T in the MSM genome at 419 bp downstream from the termination codon. With a set of PCR primers (F1 and R1) covering the polymorphic site, allele-speci®c expression was examined for MST tumors and cell lines that were derived from intersubspeci®c F 1 mice between the two strains ( Figure  1 ). Figure 2a shows SSCP analysis of the RT ± PCR products. MST1 and MST5 tumors and MST cell lines of 1-3, 4-1, 4-2, 4-3, 5-2 and 5-3 showed biallelic expression of the a4 integrin gene. On the other hand, MST3-2 and MST3-3 did not express the gene at detectable levels, and MST1-2, MST1-4 and MST1-5 showed a remarkable dierence in allelic expression, B6 allele being poorly expressed. The same analysis was performed for the nine MSTP cell lines that were obtained from MST1-4 cells by successive cloning and transplantations of tumor cells (Figure 1) . They comprised a variety of dierent metastatic properties (see Materials and methods). The two MSTP cell lines, C23 and P4, showed the same pattern as MST1-4, whereas the other seven cell lines exhibited decreased expressions of both alleles. Figure 2b shows loss of heterozygosity analysis of the a4 integrin region on mouse chromosome 2. No allelic loss was observed. This suggested the instability of the a4 integrin gene expression in the MST tumors and cell lines. The acatenin gene was examined to know intactness of the RNA samples. Biallelic expression of a-catenin RNA was detected for all samples (Figure 2c ). These results suggested that the a4 integrin gene underwent allelespeci®c inactivation in the MSTP lines.
Four cell lines, T1, T3, T4 and L2, were further obtained from a tumor induced by subcutaneous injection of P4 and examined for the integrin expression. They all showed expression loss of both alleles (Figure 3a ). This suggests that the MSM allele expressing the a4 integrin gene tended to undergo the suppression, or that the cells having lost the expression had already existed in the P4 cell population and some of those were selected during the cloning process. Two control experiments were also carried out; the SSCP pattern of DNA did not show allelic loss (Figure 3b ) and the a-catenin gene was expressed from both alleles in the four lines (Figure 3c ).
RNA amounts transcribed in P4 and its descendant lines were determined by semi-quantitative PCR assay. Serially diluted RNAs of MST1-4 and P4 were subjected to RT ± PCR and their products were compared to those of the cell lines showing the decrease of expression (Figure 4 ). 2L8 and 3K4 cells contained the a4 integrin RNA 1/50 fold less than MST1-4 did, whereas the four lines, P4T1, P4T3. P4T4 and P4L2, did not show detectable amounts of the RNA. a-catenin RNA was present in all preparations.
Five cell lines were established from a subcutaneous tumor (S1) induced by injection of another tumor line, MST4-4. The RNA analysis provided that allelic inactivation was seen in four of them; the B6 allele underwent loss of expression (Figure 5a ). One line (S1-4) exhibited remarkable decrease of expression at both alleles. DNA analysis showed no allelic loss for the four clones but loss of the B6 allele for one clone, S1-2 (Figure 5b ). Figure 5c showed the expression of the Ecadherin gene; all samples showed biallelic expression. These results suggest that allelic inactivation frequently occurs at least in ®brosarcomas induced in the F 1 mice.
Metastatic ability of MST cells
Arti®cial and spontaneous metastatic abilities of MSTP cell lines were examined to know the relationship between the allelic inactivation and acquisition of spontaneous metastatic ability. The metastatic process comprises several major steps as follows: detachment of cells from primary tumor, invasion of extracellular matrix, intravasation, arrest in the blood vessels in secondary sites, extravasation, colonixation and proliferation (Liotta et al., 1991) . Spontaneous metastasis assay in which cells were subcutaneously injected requires the abilities to overcome all the steps, whereas arti®cial metastasis assay in which cells were intravenously injected can bypass the early steps prior to intravasation. Table 1 summarizes the results of arti®cial and spontaneous metastasis assays. C23 or P4 cells showing mono-allelic expression did not show a spontaneous metastatic capacity; none of the ®ve mice subcutaneously injected developed metastatic nodules in lung for each clone. By intravenous injection of P4, however, it produced metastatic nodules for three out of four mice tested. On the other hand, 2L8 showed such ability; one produced lung metastasis of four mice examined. 3K4 showed an increased level of metastatic ability; eight of 15 mice developed metastasis. Three lines, P4T1, P4T3 and P4T4, newly obtained from P4 each gained the ability to metastasize spontaneously. We did not examine the clones derived from S1, because they expressed Ecadherin that could prevent the metastatic spread in an early step (Vleminckx et al., 1991) . These results suggested that the expression loss or decrease of a4-integrin gene gave a propensity for metastasizing spontaneously to 2L8, 3K4, P4T1, P4T3 and P4T4.
Suppression of metastasis by overexpression of a4-integrin
To con®rm the suppressive activity of a4-integrin, we performed a gene transfer experiment as previously done for B16 melanoma (Neuhaus et al., 1991; Qian et al., 1994) . Two cell lines, 3K4-a4 and 3K4-a4-I, that augmented the mouse a4-integrin gene with the normally and inversely oriented promoter, respectively, were established by transfection into 3K4 cells. Subcutaneous injection of 3K4-a4 cells produced tumors expressing a4-integrin mRNA in six out of the nine mice inoculated. The six tumors showed an expression level higher than that of MST1-4 cells as assayed by semi-quantitative PCR (data not shown). None of the six mice bearing tumor of that type developed metastatic lesion (Table 1) , while one of the Table 1 Figure 2 Allele-speci®c expression of the a4-integrin gene. RT ± PCR ± SSCP and SSCP analyses of the a4-integrin gene (a and b) and RT ± PCR ± SSCP analysis of the a-catenin gene (c). RT ± PCR was carried out for RNA obtained from liver of parental and F 1 mice, MST tumors and a series of the cell lines. One primer was end-labeled with 32 P and used for the ampli®cation. PCR products were heat-denatured and separated by 8% polyacrylamide gel electrophoresis. After electrophoresis, the gel was dried and autoradiographed. No band signals were obtained from RNA templates without the treatment with reverse transcriptase. DNAs and RNAs used are indicated above the gel lanes. The region showing double-stranded DNA is not included in this photograph remaining three mice carrying integrin-unexpressed tumor produced the lesion. In contrast, the control 3K4 ± a4-I cells retained a metastatic potential; three out of the six mice bearing tumor with expression gave metastatic nodules in lung (Table 1) .
Loss of heterozygosity analysis
P4, 2L8 and 3K4 cells were subjected to loss of heterozygosity analysis using 64 microsatellite markers distributed throughout the mouse genome. No allelic loss was detected in the P4 and 2L8 cells, whereas, in the 3K4 cells, two markers of D2Jpk4 on chromosome 2 and D5Jpk2 on chromosome 5 exhibited loss of the B6 allele and the MSM allele, respectively (data not shown). Since these losses were not seen in the 2L8 cells having acquired spontaneous metastatic ability, none of the losses seemed to aect metastatic capacity.
DNA methylation and chromatin state of the a4 integrin gene
The allelic inactivation of a4 integrin gene may be due to epigenetic change, since no allelic loss was detected and the frequency was considerably high. Therefore, allelic dierences in DNA methylation and chromatin state of the gene were investigated. There is a GC-rich region approximately 100 bp upstream from the transcription start site which contains the recognition sequence of methylation-sensitive restriction enzyme, HpaII. Besides, sequence analysis revealed a polymorphism between the two strains; T residue at 75 from the start site in B6 is changed to C in MSM. Hence, a set of primers (F2 and R2) spanning this region was synthesized and used for PCR amplification. As shown in Figure 6 , SSCP analysis showed that all DNA samples without digestion gave Semi-quantitative analysis of RNA amounts in MST cell lines. RNA of MST1-4 and P4 cells were diluted as indicated above the lanes, and subjected to PCR as described in the legend to Figure 2 . PCR products were heat-denatured and separated by 8% polyacrylamide gel electrophoresis polymorphic bands of B6 and MSM alleles, whereas HpaII DNA digests of MST1, MST1-4, P4 and 3K4 cells provided no bands of either allele. The result indicated that this region was not methylated irrespective of expression of the a4 integrin gene. On the other hand, four clones derived from P4 underwent methylation at the B6 allele more highly than at the MSM allele, but the methylation did not parallel inactivation of the allele.
HaeIII enzyme sensitivity was examined for the chromatin of the promoter region of a4 integrin gene. Nuclei were isolated from MST1-4 and 2L8 cells and digested with various concentrations of HaeIII. DNA samples puri®ed were analysed by PCR using the primer set used for methylation, because the ampli®ed region contained three HaeIII recognition sites. No dierence was seen in band-signal ratios between B6 and MSM alleles irrespective of amounts of the enzyme added, indicating no signi®cant dierence in HaeIII sensitivity ( Figure 7) . Success of the digestion was monitored by probing the Xist gene on X chromosome as a control; the transcribed MSM allele was more sensitive than the nontranscribed B6 allele (data not shown). These results indicated that the DNA methylation and the chromatin state did not change allele-speci®cally in parallel to the allelic inactivation of a4 integrin gene.
Discussion
In this study we have examined the allele-speci®c expression of a4 integrin gene in MST ®brosarcoma lines with dierent metastatic potential. These lines are derived from intersubspeci®c heterozygous mice between C57BL/6 and MSM and hence useful for such study through ecient detection of polymorphisms. It is demonstrated that the a4 integrin gene lost the expression in an allele-speci®c or two-step manner and the loss was related to the acquisition of spontaneous metastatic ability. Two cell lines of MST1-4 and P4 expressed the a4 integrin gene at 1,3) n.t. a a4-integrin expression from data shown in Figures 2 and 3 . B/M, biallelic expression; M, monoallelic expression from the MSM allele; no, no or little expression observed; yes, the transfected a4-integrin gene expression (data not shown). b Assayed by injection of cells subcutaneously as described in Materials and methods. n.t., not tested; fractions, number of mice forming metastatic nodules per number of mice injected; parentheses, number of metastatic nodules; m, more than 10. Dierence in metastatic potential between a4-integrin expressing clones (C23 and P4) and others without expression is statistically signi®cant: P=0.027.
c Assayed by injection of cells intravenously (see Materials and methods) levels comparable to liver, although the expression was monoallelic. On the other hand, the descendent lines of P4 exhibited decreased expression of both alleles. Their RNA amounts were 1/50-fold less than that of the parental MST1-4 line. Other four independent clones derived from P4 and ®ve clones from another tumor also showed such allele-speci®c inactivation. These results suggest a frequent occurrence of allelic inactivation of the a4-integrin gene at least in MST tumor lines. Of importance is that the clones showing loss of the expression were able to produce metastatic nodules in lung by subcutaneous injection of the cells. In contrast, P4 cells expressing the a4 integrin gene did not provide such nodules, although they were able to metastasize by intravenous injection. This correlation between the expression loss and the acquisition of spontaneous metastasis is consistent with that observed in B16 melanoma variants (Qian et al., 1994) . Cell surface adhesion molecules including integrins, cadherins, catenins and CD44 play important roles in tumor progression and metastasis (Qian et al., 1994; Paavonen et al., 1994; Shimoyama and Hirohashi, 1991; Morton et al., 1993; Ochiai et al., 1994; Risinger et al., 1994; Gao et al., 1997) . Integrins consist of an a subunit noncovalently associated with a b subunit and are divided into at least eight subfamilies, each de®ned by a common b subunit (Hynes, 1992; Ruoslahti and Reed, 1994) . The b1 subfamily has been considered to be the primary mediator of extracellular matrix adhesions and also to mediate cell to cell adhesion directly. The homotypic contacts between tumor cells due to the integrin may well prevent metastatic spread at a stage of detachment of cells from primary tumor (Liotta, 1991; Hynes and Lander, 1992) . This is an early event in the invasive stage of tumor metastasis (Liotta, 1991) . It was reported that the expression of a4b1 integrin is inversely correlated with the invasive potential of B16 melanoma cell lines; its overexpression on the highly metastatic cells by retroviral transfer provides a marked suppression of the metastasis in the spontaneous metastasis assay (Qian et al., 1994) . This indicated that a4b1 integrin plays a role in controlling tumor metastasis at the invasive stage. We have con®rmed the correlation in the 3K4 ®brosarcoma cells by transfection of the a4 integrin gene (Table 1) . E-cadherin, another cell adhesion molecule, may also play a similar role in prevention of the invasion. Either Figure 6 Methylation status of two alleles in the a4-integrin gene. HpaII DNA digests, together with non-digests, were analysed by PCR with the primer set (F2 and R2) amplifying the promoter region. In this region one HpaII recognition site and one polymorphic site exist. PCR products were heat-denatured and separated by 8% polyacrylamide gel electrophoresis Figure 7 Accessibility of the promoter region of a4-integrin gene to HaeIII enzyme. Nuclei were treated with increasing concentrations of HaeIII (from 50 ± 1600 units/ml indicated above lanes) and analysed using the PCR primers used for methylation analysis. The patterns obtained are slightly dierent from those in Figure 6 though similar experimental conditions used. This is due to the presence of multiple forms of single-stranded DNA in SSCP analysis which are rarely formed in exactly similar quantities from experiment to the next of the MST1-4 cell lines and the B16 melanomas did not express E-cadherin.
Reduced expression of some integrins occurs relatively frequently in invasive cancers of various types of tumor: e.g., colorectal adenocarcinomas and their liver metastasis (Pignatelli et al., 1990; Koretz et al., 1991; Nigam et al., 1993) ; lung cancers (Damjanovich et al., 1992; Suzuki et al., 1993) ; and skin cancers (Peltonen et al., 1989) . E-cadherin also underwent loss or down-regulation and mutations in a variety of human cancers (Shimoyama and Hirohashi, 1991; Morton et al., 1993; Risinger et al., 1994) . These ®ndings suggest loss of certain adhesion molecules conferring an increased level of malignancy.
Our ®nding is not only a con®rmation of the relationship between a4 integrin and metastasis described for B16 melanomas, but provide a novel implication that the allelic inactivation of a4 integrin gene is a factor involved in acquisition of metastatic ability at least in some of the MST lines. Expression of the a4 integrin was the determinant of function of a4b1 integrin molecules in these cell lines, since they consistently expressed the b1 subunit (data not shown). The total loss of function of a gene within the cell is achieved by inactivation of both alleles according to Knudson's two-hit theory. The inactivation results from a variety of the following mechanisms: point mutations, regional deletions, a chromosome loss, and probably epigenetic impairments. The allelic loss of a4 integrin gene in MST lines might be due to DNA mutations which occurred in regions controlling gene expression or those aecting the mRNA stability. However, it is more likely that the expression loss is caused by epigenetic changes, because the frequency was high and no allelic loss of DNA was observed. Involvement of such epigenetic change in the cancer development is well documented for imprinted genes (Ogawa et al., 1993; Rainier et al., 1993; Cost et al., 1997; Kaghad et al., 1997) .
We have searched genes that show allele-speci®c loss of expression in this heterozygous tumor cell. Four genes of the 14 polymorphic genes examined have such property (Ohtsuka et al., 1994) . They are the genes encoding p53, E-cadherin, glucose transporter 3, and thymidine kinase. These data, together with this study, suggests that allele-speci®c inactivation might be a common event in tumor cells. Intriguingly, there seems to be allelic preference in the expression loss in MST lines between the B6 and MSM alleles. The B6 allele lost or decreased the expression of the a4 integrin gene earlier than the MSM allele, which was exempli®ed by MST1-4, C23 and P4. Their descendant lines also showed decreased levels of the expression in MSM allele. As for E-cadherin, the MSM allele maintains expression more than the B6 allele, whereas as to thymidine kinase the B6 allele is expressed more than the MSM allele. On the other hand, p53 and glucose transporter 3 do not show such preference (Ohtsuka et al., 1994) . The reason for allelic preference is unclear at present.
Changes in the pattern of DNA methylation are commonly seen in human and animal tumors (Laird and Jaenisch, 1994; Ushijima et al., 1997; Akama et al., 1997) . Aberrant methylation is often correlated with loss of expression of the normal Rb, p16, oestrogen receptor, VHL or E-cadherin mRNA (Sakai et al., 1991; Ohtani-Fujita et al., 1993; Makos et al., 1993; Issa et al., 1994; Herman et al., 1995; Gonzalez-Zulueta et al., 1995; Merlo et al., 1995; Yoshiura et al., 1995) . It is possible, therefore, that DNA methylation is a mechanism of silencing the a4 integrin gene. Besides, frequent alteration of DNA methylation in a region of this gene is found in the mouse liver tumors (Akama et al., 1997) . Our examination of MSTP cell lines showed that most of them were not methylated and two lines exhibited allele-speci®c changes. However, such methylation did not parallel the allelic inactivation of a4 integrin gene (Figure 6 ). Examination of changes at the chromatin level also could not give a clue to allelic inactivation ( Figure 7) . Thus, we failed to ascribe the allelic inactivation to dierence either in the DNA methylation or the chromatin state, although the inactivation is probably due to errors in epigenetic modi®cation processes in tumor cells. Inactivation of this type could be a process providing loss of function to one allele, and therefore a combination of this with one of other inactivation mechanisms would lead to the function loss of a given gene through impairment of both alleles of the gene.
Materials and methods
Mouse, cell lines and metastasis assay F 1 mice were obtained by mating C57BL/6(B6) females with MSM males. MSM is an inbred strain derived from Japanese wild mice, Mus musculus molossinus (Bonhomme and Guenet, 1989) . Mice were kept in plastic cages at an air-conditioned room and given commercial pellets and tap water ad libitum.
Establishment of some of the MST tumors and cell lines used in this study is described previously (Ohtsuka et al., 1994) . In brief, they originate in the F 1 mice between B6 and MSM. C23 is an in vitro clone of MST1-4 cells that was obtained from MST1 tumor. P-4 cell line was established by cloning of C23 after 3 month culture. 2L8 and 2HC were obtained from lung and liver metastatic nodules, respectively, produced by intravenous injection of P4. Six lines (SCL1, L-b, 3K4, K4SC2-1, 2HC and 1-L-1) were derived from 2L8. C-23 and P-4 were not able to give metastatic nodules with subcutaneous injection. In contrast, 2L8 and the descendant lines had a metastatic potential.
Several cell lines were newly established. T1, T3, T4 and L2 cells were obtained from tumors and a lung metastatic nodule induced by subcutaneous injection of P4 cells. S1 tumor and ®ve cell lines were similarly yielded from an independent tumor cell line, MST4-4. The procedure was described previously (Takada et al., 1992) . In brief, tumors and metastatic nodules were aseptically cut o and minced with scissors, and tissue explants were subjected to in vitro culture. When cells migrating and proliferating from tissue explants were near con¯uency, they were transferred to culture bottles. The MST cultures were maintained at 378C in 5% CO 2 and 95% air in a-modi®ed minimum essential medium supplemented with 10% fetal bovine serum, 100 mg/ ml streptomycin and 100 U/ml penicillin.
Metastasis assay was performed as previously described (Takada et al., 1992; Mafune et al., 1994) . F 1 mice crossed between B6 and MSM were used for testing the tumor metastasis. Eight-to ten-week-old F 1 mice were given a single subcutaneous inoculation of 5610 5 cells. When the primary tumor reached 10 cm 3 (4 ± 6 weeks after inoculation), the tumor-bearing mice were sacri®ced and examined for lung metastasis. In some cell lines, cells were also given intravenously.
Expression of a4 integrin cDNA A 2.9 kb DNA fragment containing the full-length mouse a4 integrin cDNA (Neuhaus et al., 1991) was inserted into the mammalian expression vector pMKITNeo (K Maruyama, unpublished data), which primarily contains the promoter of the SRa vector, in either sense or antisense orientation. 15 mg of the plasmid DNA was transfected into 3K4 cells by a standard electroporation technique. Transfected cells were incubated in a-modi®ed minimum essential medium supplemented with 10% fetal bovine serum for 2 days and then grown in the same medium containing 200 mg/ml of G418. Among several clones isolated, a clone containing the plasmid with sense orientation (3K4-a4) and a clone containing the plasmid with antisense orientation (3K4-a4-I) were chosen and used for the metastasis assay described above. These cells expressed a4-integrin mRNA and anti-RNA, respectively, at a level higher than that of MST1-4 cells as assayed by semi-quantitative PCR (data not shown).
Isolation of DNA and RNA and preparation of cDNA Cellular DNA was extracted using proteinase K as described previously . Total cellular RNA was obtained from tumors and cell lines using the RNA preparation kit (Nippon Jin Corp., Toyama, Japan). RNA pellets were dissolved in TE buer (10 mM TrisHCl, pH 7.4 and 0.1 mM EDTA) and subjected to synthesis of cDNA; RNA (10 mg) was denatured at 738C for 3 min and annealed with 40 pmol of oligo-dT primers or 10 pmol of sequence-speci®c anti-sense-strand primers. Nine units of avian myeloblastosis virus (AMV) reverse transcriptase (Life Science, Inc.) was used to transcribe mRNA into cDNA. The reaction was carried out in 50 mM Tris-HCl, pH 8.3, 50 mM KCl, 8 mM MgCl 2 , 4 mM DTT, 1 mM dNTP at 428C, for 2 h.
PCR and SSCP analysis
Primers for polymerase chain reaction (PCR) were synthesized according to sequences reported. Sequences for forward and reverse primers are as follows: a 3' region of a4 integrin, F1: 5'-CACCACATTCTGTCATA-GAAATG-3': R1: 5'-GTGAAACCCAGGTAGAAGCTA-3'; a promoter region of a4 integrin, F2: 5'-CCACTGTGTGTGATGTCTGC-3'; R2: 5'-GATGAAG-TGCAGCAGCGTGTC-3'; a-catenin, F: 5'-GCATGGCT-ACAGTTACTAATG-3', R: 5'-TGAGCCCGATGGTGA-ATTTG-3'. The primers for E-cadherin are as described (Ohtsuka et al., 1994) .
PCR was carried out for cDNA and cellular DNA in a 10 ± 20 ml volume under conditions as described (Saiki et al., 1988; Mafune et al., 1994) . One primer was end-labeled with 32 P and used for ampli®cation. The reaction was processed through 30 ± 35 cycles of ampli®cation consisting of 1 min at 948C, 1 min at 558C and 1 min at 728C, with the last elongation step lengthened to 10 min. In some cases Mg 2+ ion in the buer was increased to 3 mM. For single strand conformation polymorphism (SSCP) analysis, the products were heat-denatured and separated by 8% polyacrylamide gel electrophoresis (Orita et al., 1989) . We certi®ed no contamination of cellular DNA in RNA samples by control PCR without the reverse transcriptase treatment; the reactions did not give any detectable PCR products. As for analysis of the DNA methylation state, PCR ± SSCP analysis was carried out for DNA digested with HpaII or HhaI in the same manner.
The ®delity of PCR products showing polymorphism was examined of the a4 integrin and a-catenin genes by segregation analysis using 61 backcross mice (data not shown). The strain distribution pattern was each conformed to a chromosomal location of the gene reported (Copeland et al., 1993) .
Microsatellites for allelic loss analysis
